Benefit of prebiotic in reducing loose motions among cancer patients experiencing radiotherapy

Not Applicable

Completed

• Conditions: Cancer patient (endometrium, cervix, colon, rectum and prostate) undergoing pelvic radiation treatment; Cancer

• Registration Number: ISRCTN17271186
• Lead Sponsor: Bio Scenergy Sdn Bhd

Brief Summary

2020 results in https://pubmed.ncbi.nlm.nih.gov/32740950/ (added 04/08/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2016-04-08
• Study Start: 2019-11-09
• Last Update Posted: 17 August 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Cancer patient with pelvic cancers scheduled for external beam radiotherapy (EBRT) treatment as an outpatient or inpatient with EBRT dose 40 Gray and above, 180-220 cGy per fraction

Exclusion Criteria

Patients receiving enteral or parenteral nutrition or terminally ill

Study & Design

• Study Type: Interventional
• Study Design: Not specified